Arch Suicide Res. 2022 Oct-Dec;26(4):1794-1814. doi: 10.1080/13811118.2022.2028207. Epub 2022 Feb 9.
This PRISMA scoping review explored worldwide research on the delivery of suicide-specific interventions through an exclusive telehealth modality. Research over telehealth modalities with suicidal individuals highlights the importance of facilitating participants' access to treatments despite location and circumstances (e.g., rural, expenses related to appointments, etc.).
The review sought evidence of outcomes of trials or projects in which both the patient and therapist attended sessions conjointly and openly discussed suicide over a telehealth modality (e.g., phone, zoom).
To explore this topic the authors searched for research trials and quality improvement projects using Ovid Medline, Ovid Embase, Ovid PsycINFO, EBSCO Social Services Abstracts, and Web of Science on 3/3/2021.
Nine different articles were included that each spanned distinct treatments, with eight being research studies and one being a quality improvement project.
Publications featuring ongoing or upcoming research in which complete study results were not available did not meet inclusion criteria for this review.
Several important research gaps were identified. While this approach has been largely understudied, exclusive telehealth delivery of suicide-specific interventions has great potential for the prevention of suicidality, especially in the era of COVID-19 and beyond.
本 PRISMA 范围综述探讨了通过专门的远程医疗模式在全球范围内开展的自杀特定干预措施的研究。对使用远程医疗模式治疗自杀个体的研究强调了尽管地点和情况(例如,农村地区、预约相关费用等)不同,仍要为参与者提供治疗的重要性。
综述旨在寻找在远程医疗模式(例如电话、视频会议)中患者和治疗师共同参加会议并公开讨论自杀问题的试验或项目的结果证据。
为了探讨这一主题,作者于 2021 年 3 月 3 日在 Ovid Medline、Ovid Embase、Ovid PsycINFO、EBSCO 社会服务摘要和 Web of Science 上搜索了研究试验和质量改进项目。
共纳入了 9 篇不同的文章,每篇文章都涵盖了不同的治疗方法,其中 8 篇是研究论文,1 篇是质量改进项目。
本综述的纳入标准是研究结果完整的已发表的研究,不包括正在进行或即将进行的研究的出版物。
确定了几个重要的研究差距。虽然这种方法在很大程度上研究不足,但专门的远程医疗模式提供自杀特定干预措施具有很大的预防自杀的潜力,尤其是在 COVID-19 时代及以后。